Axogen's ROE % for the quarter that ended in Dec. 2023 was -16.10%. Axogen's PB Ratio for the quarter that ended in Dec. 2023 was 3.08.
Axogen's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -5.23%.
Axogen ROE % Adjusted to Book Value Historical Data
The historical data trend for Axogen's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Axogen's ROE % Adjusted to Book Value
For the Medical Devices subindustry, Axogen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Axogen's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Axogen's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Axogen's ROE % Adjusted to Book Value falls into.
Axogen ROE % Adjusted to Book Value Calculation
Axogen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Axogen ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of Axogen's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AXGN has been successfully added to your 